Dear all..another interesting trial conducted on Ewing's sarcoma - a cancer that affects in or near the bones mainly in teenage boys. The drug under case study is figitumumab which was found to be more effective in treating this sarcoma. The drug must undergo two more phases of testing, however, according to a report published in the Dec. 23 online edition of "The Lancet Oncology".
Shocking news!!!!! Basing on a complaint received from Superindent of King George Hospital (KGH), one of the ancient hospitals in Visakhapatnam, Drug inspector of Vizag inspected the medical store at KGH and found a "suspended black mass like matter" in "SODIUM LACTATE INJECTION" and "undissolved matter" in "PENTASOL IV INJECTION". While sending the drug samples to DCL (Hyderabad), the DI ATV Ramadevi advised the consumers, chemists, doctors and Govt. Hospitals not to use these two drugs.
Heres another interesting news..Rabies vaccine protects against monkey's version of HIV ie.,SIV - simian equivalent of HIV. This effort may pave a new path for developing HIV vaccine.
DEAR ALL..a new press release by Pfizer..
As told in previous blog..women mostly suffer from cervical,breast cancer. The post menopausal breast cancer is the common one..
Everyone is aware of TAMOXIFEN..it is an antineoplastic agent used to treat post menopausal breast cancer.
Adding chemotherapy to standard cancer-suppressing tamoxifen can boost survival in postmenopausal women with the most common type of breast cancer, known as estrogen receptor-positive, and it's best given before the tamoxifen regimen starts, according to a new study.
Another interesting concept i happened to see is that breast feeding helps mom's heart decade later..
According to the latest information available, breast feeding for atleast couple of months can lower a woman's risk of metabolic syndrome -- a dangerous cluster of heart disease risk factors -- years later. Here goes to the original context..
This year we celebrated Pharmacy week with a zest. Every one was actively participating in the various activities taken by our institution Yalamarty Pharmacy College – Visakhapatnam.
FDA approved a new drug ABILIFY for Irritability associated with autistic disorder in Pediatric Patients of age 6 to 17 years.
Autism is a disorder of neural development that is characterized by impaired social interaction and communication, and by restricted and repetitive behavior. These signs all begin before a child is three years old.
LYSTEDA (tranexamic acid) Tablets
Date of Approval: November 16, 2009
Company: Xanodyne Pharmaceuticals, Inc.
Treatment for: Menorrhagia
ISTODAX (romidepsin) for Injection
Date of Approval: November 5, 2009
Company: Gloucester Pharmaceuticals
Treatment for: Cutaneous T-cell Lymphoma
PENNSAID(diclofenac sodium) Topical Solution
Date of Approval: November 4, 2009